{"ticker": {"uuid": "3e17f3b8-0331-48fe-aa88-933b16ca9999", "symbol": "002294", "name": "Shenzhen Salubris Pharmaceuticals Co., Ltd.", "exchange": "SHZ", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Enterprise value to EBIT forward of Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A \u2013 SZSE:002294", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNUHFoR0J6NVlRTWNpODdndFJ2M2UweG1sR2Viem9PM2kyUjZaRHNnMjF3Q3hBdUpyVHU5V2lrWmNkeFJuRXdUUFVodlVWYUJqUGd6RmdsV0ZOcUV4MWNOSW5HTzJianl5MUNfNlM1YVhBaFFWc1A0QUtfZHZOSWtkRFhWUWVSVF9ITG90OGdMLWhxVWpfbUVKSjhZYzlfYUdfaVAtTENOdHlqQUE?oc=5", "source_name": "TradingView", "published_at": "2026-07-05T22:07:44+00:00", "published_display": "05 Jul 2026 22:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IPO News | Salubris (002294.SZ) Files Listing Application with HKEX, Ranked as the Second Largest Pharmaceutical Enterprise in China\u2019s Cardiovascular Innovative Drug Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPTm1WLThxdTRnOFNjeUtvUl9ZWjRRa2doY3N5cXFNU2hkb0g5MGtiWHpxVEZidzJ4eTFGVDgtdGJ4bldKRmdhYmUydWkyZ2Y2c3RSN18tLWxQRG55VTN2U0w0SEI0WXJhNG9VbzAxYndlTFNjRU9Nc1dtdi05OU1WVHM3dmRDTTNMa1dVYk00cGJad0stZk1zTXpmd1BXZDM1NElPTXlOUEU?oc=5", "source_name": "Moomoo", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yoltech licenses gene editing therapy to Salubris for $145M", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOeUE5dVZhSmU5blpzcmNDYkxiQU1xdlRHQW5NTUx6dXItdGJQWGdHRHFzWXFKUXFUQlZqa0V0dkpUUWdDWjVCUld0WmZ4Q0o3ZjdXUUxGaUhaaUVCXzYteDFGczRhUEg5YU5vWkxpaUJyX3laVzJhYWNrYjdVR0I1eU1taHRUZW5IZ2tpVTIzTkpHc3pGTXFBaUxDZ09RVUdI?oc=5", "source_name": "BioWorld News", "published_at": "2024-08-29T07:00:00+00:00", "published_display": "29 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Enterprise value to EBIT forward of Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A \u2013 SZSE:002294", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNUHFoR0J6NVlRTWNpODdndFJ2M2UweG1sR2Viem9PM2kyUjZaRHNnMjF3Q3hBdUpyVHU5V2lrWmNkeFJuRXdUUFVodlVWYUJqUGd6RmdsV0ZOcUV4MWNOSW5HTzJianl5MUNfNlM1YVhBaFFWc1A0QUtfZHZOSWtkRFhWUWVSVF9ITG90OGdMLWhxVWpfbUVKSjhZYzlfYUdfaVAtTENOdHlqQUE?oc=5", "source_name": "TradingView", "published_at": "2026-07-05T22:07:44+00:00", "published_display": "05 Jul 2026 22:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IPO News | Salubris (002294.SZ) Files Listing Application with HKEX, Ranked as the Second Largest Pharmaceutical Enterprise in China\u2019s Cardiovascular Innovative Drug Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPTm1WLThxdTRnOFNjeUtvUl9ZWjRRa2doY3N5cXFNU2hkb0g5MGtiWHpxVEZidzJ4eTFGVDgtdGJ4bldKRmdhYmUydWkyZ2Y2c3RSN18tLWxQRG55VTN2U0w0SEI0WXJhNG9VbzAxYndlTFNjRU9Nc1dtdi05OU1WVHM3dmRDTTNMa1dVYk00cGJad0stZk1zTXpmd1BXZDM1NElPTXlOUEU?oc=5", "source_name": "Moomoo", "published_at": "2026-02-12T08:00:00+00:00", "published_display": "12 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Yoltech licenses gene editing therapy to Salubris for $145M", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOeUE5dVZhSmU5blpzcmNDYkxiQU1xdlRHQW5NTUx6dXItdGJQWGdHRHFzWXFKUXFUQlZqa0V0dkpUUWdDWjVCUld0WmZ4Q0o3ZjdXUUxGaUhaaUVCXzYteDFGczRhUEg5YU5vWkxpaUJyX3laVzJhYWNrYjdVR0I1eU1taHRUZW5IZ2tpVTIzTkpHc3pGTXFBaUxDZ09RVUdI?oc=5", "source_name": "BioWorld News", "published_at": "2024-08-29T07:00:00+00:00", "published_display": "29 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 48, "total_relevant": 3, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 3, "score": 50, "total": 3, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 37.26, "latest_week": "2026-07-17", "one_week_move": 0.4, "four_week_move": 22.6, "twelve_week_move": -31.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.474236, "market_dynamics_buy_signal": false, "relative_strength": -26.985799, "fair_value_gap": -0.4, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 45.3693, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.4% over one week, +22.6% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 47, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 1}, {"label": "Moomoo", "count": 1}, {"label": "BioWorld News", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 3}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "3", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.4% over one week, +22.6% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Enterprise value to EBIT forward of Shenzhen Salubris Pharmaceuticals Co., Ltd. Class A \u2013 SZSE:002294"}], "updated_at": "2026-07-22T08:40:25.641039+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}